Table 1 Available diagnostic information for all AD cases
AD subject | Age (years) | MMSE | Neuropsychol. assessment | Structural MRI | FDG PET | Amyloid-PET | CSF | Duration of follow-up (years) |
|---|---|---|---|---|---|---|---|---|
1 | 82 | 15 | + | +/− | − | − | − | 10.5 |
2 | 69 | 18 | + | − | + | − | − | 1 |
3 | 63 | 22 | + | + | − | − | − | 2 |
4 | 67 | 27 | + | + | − | − | − | 4.5 |
5 | 62 | ≤ 8* | + | +/− | − | + | + | 3.5 |
6 | 73 | 17 | + | + | − | − | − | 1.5 |
7 | 74 | 10 | – | + | + | − | − | 2 |
8 | 76 | 14 | – | + | − | − | − | 1 |
9 | 71 | 15 | + | + | + | − | + | 7 |
10 | 81 | 17 | + | + | − | − | − | 6 |
11 | 79 | 22 | + | + | + | − | + | 1 |
12 | 77 | 20 | + | +/− | +/− | − | + | 4 |
13 | 72 | 22 | + | + | + | − | − | 3.5 |
14 | 70 | 14 | – | + | + | − | + | 1.5 |
15 | 73 | 24 | + | + | − | − | − | 1.5 |
16 | 75 | 24 | + | + | + | − | + | 5 |
17 | 58 | 10 | – | + | + | − | + | 1.5 |